Water-soluble coenzyme Q10 provides better protection than lipid-soluble coenzyme Q10 in a rat model of chronic tacrolimus nephropathy
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Coenzyme Q10 (CoQ10), is a promising antioxidant; however, low bioavailability owing to lipid-solubility is a limiting factor. We developed water-soluble CoQ10 (CoQ10-W) and compared its effects with conventional lipid- soluble CoQ10 (CoQ10-L) in an experimental model of chronic tacrolimus (Tac) nephropathy. Methods: CoQ10-W was developed from a glycyrrhizic-carnitine mixed layer CoQ10 micelle based on acyltransferases. Chronic nephropathy was induced in rats with 28-day Tac treatment; they were concomitantly treated with CoQ10-L or CoQ10-W. CoQ10 level in plasma and kidney were measured using liquid chromatography– mass spectrometry. CoQ10-W and CoQ10-L effects on Tac-induced nephropathy were assessed in terms of renal function, histopathology, oxidative stress, and apoptotic cell death. Their effects on cell viability and reactive oxygen species (ROS) production were assessed in cultured proximal tubular cells, human kidney 2 (HK-2) cells. Results: The plasma CoQ10 level was significantly higher in the CoQ10-W group than in the CoQ10-L group. Tac treatment caused renal dysfunction, typical pathologic lesions, and oxidative stress markers. Serum creatinine was restored in the Tac + CoQ10-L or CoQ10-W groups compared with that in the Tac group. CoQ10-W administration reduced oxidative stress and apoptosis markers. Mitochondrial ultrastructure assessment revealed that the addition of CoQ10-L or CoQ10-W with Tac increased mitochondrial size and number than Tac treatment alone. In vitro investigations revealed that both CoQ10-L and CoQ10-W improved cell viability and reduced ROS production in the Tac-induced HK-2 cell injury. Conclusions: CoQ10-W has a better therapeutic effect in Tac-induced renal injury than conventional CoQ10-L, possibly associated with improved CoQ10 bioavailability.
Abstract
Background/Aims: Coenzyme Q10 (CoQ10), is a promising antioxidant; however, low bioavailability owing to lipid-solubility is a limiting factor. We developed water-soluble CoQ10 (CoQ10-W) and compared its effects with conventional lipid- soluble CoQ10 (CoQ10-L) in an experimental model of chronic tacrolimus (Tac) nephropathy. Methods: CoQ10-W was developed from a glycyrrhizic-carnitine mixed layer CoQ10 micelle based on acyltransferases. Chronic nephropathy was induced in rats with 28-day Tac treatment; they were concomitantly treated with CoQ10-L or CoQ10-W. CoQ10 level in plasma and kidney were measured using liquid chromatography– mass spectrometry. CoQ10-W and CoQ10-L effects on Tac-induced nephropathy were assessed in terms of renal function, histopathology, oxidative stress, and apoptotic cell death. Their effects on cell viability and reactive oxygen species (ROS) production were assessed in cultured proximal tubular cells, human kidney 2 (HK-2) cells. Results: The plasma CoQ10 level was significantly higher in the CoQ10-W group than in the CoQ10-L group. Tac treatment caused renal dysfunction, typical pathologic lesions, and oxidative stress markers. Serum creatinine was restored in the Tac + CoQ10-L or CoQ10-W groups compared with that in the Tac group. CoQ10-W administration reduced oxidative stress and apoptosis markers. Mitochondrial ultrastructure assessment revealed that the addition of CoQ10-L or CoQ10-W with Tac increased mitochondrial size and number than Tac treatment alone. In vitro investigations revealed that both CoQ10-L and CoQ10-W improved cell viability and reduced ROS production in the Tac-induced HK-2 cell injury. Conclusions: CoQ10-W has a better therapeutic effect in Tac-induced renal injury than conventional CoQ10-L, possibly associated with improved CoQ10 bioavailability.
참고문헌 (26)
- Naesens M, "Calcineurin inhibitor nephrotoxicity", Clin J Am Soc Nephrol, 4, pp.481~508 (2009)
- Lim SW, "Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K", AKT pathway during tacrolimus-induced oxidative stress, 2017, pp.8, e2972~
- Yoon HE, "Statin upregulates the expression of klotho, an anti-aging gene, in experimental cyclosporine nephropathy", Nephron Exp Nephrol, 120, pp.e123~e133 (2012)
- Piao SG, "Influence of N-acetylcysteine on Klotho expression and its signaling pathway in experimental model of chronic cyclosporine nephropathy in mice", Transplantation, 96, pp.146~153 (2013)
- Bergamini C, "A water soluble CoQ10 formulation improves intracellular distribution and promotes mitochondrial respiration in cultured cells", PLoS One, 7, pp.e33712~ (2012)
- Yubero D, "Biochemical diagnosis of coenzyme q10deficiency", Mol Syndromol, 5, pp.147~155 (2014)
- Littarru GP, "Clinical aspects of coenzyme Q10 : an update", Curr Opin Clin Nutr Metab Care, 8, pp.641~646 (2005)
- Bhagavan HN, "Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations", Mitochondrion, 7(Suppl), pp.S78~S88 (2007)
- Silver MA, "Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction", Am J Cardiol, 94, pp.1306~1310 (2004)
- Beg S, "Bioavailability enhancement of coenzyme Q10 : an extensive review of patents", Recent Pat Drug Deliv Formul, 4, pp.245~255 (2010)
- Xue R, "Coenzyme Q10 inhibits the activation of pancreatic stellate cells through PI3K", AKT, Oncotarget, pp.2017, 8[DOI]
- Ulla A, "Coenzyme Q10prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats", BMC Pharmacol Toxicol, 18, pp.29~ (2017)
- Prangthip P, "An improvement of oxidative stress in diabetic rats by ubiquinone-10 and ubiquinol-10 and bioavailability after short-and long-term coenzyme Q10 supplementation", J Diet Suppl, 13, pp.647~659 (2016)
- Ozcan P, "Can coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage?", J Assist Reprod Genet, 33, pp.1223~1230 (2016)
- Huo J, "Coenzyme Q10 prevents senescence and dysfunction caused by oxidative stress in vascular endothelial cells", Oxid Med Cell Longev, 2018, pp.3181759~ (2018)
- 선인오, "The effects of addition of coenzyme Q10 to metformin on sirolimus-induced diabetes mellitus", The Korean Journal of Internal Medicine, 34(2), pp.365~374 (2019), 대한내과학회[DOI]
- Jin J, "Effect of empagliflozin on tacrolimus-induced pancreas islet dysfunction and renal injury", Am J Transplant, 17, pp.2601~2616 (2017)
- Visconti GL, "Determination by UPLC", MS-MS of coenzyme Q10(CoQ10)in plasma of healthy volunteers before and after oral intake of food supplements containing CoQ10, 2015, pp.6(S13), 011~
- Lim SW, "Ginseng treatment attenuates autophagic cell death in chronic cyclosporine nephropathy", Nephrology (Carlton), 19, pp.490~499 (2014)
- Doh KC, "Ginseng treatment attenuates chronic cyclosporine nephropathy via reducing oxidative stress in an experimental mouse model", Am J Nephrol, 37, pp.421~433 (2013)
- Li C, "Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy", Am J Physiol Renal Physiol, 286, pp.F46~F57 (2004)
- Luo K, "Therapeutic potential of coenzyme Q10 in mitochondrial dysfunction during tacrolimus-induced beta cell injury", Sci Rep, 9, pp.7995~ (2019)
- Yi Quan, "The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus", The Korean Journal of Internal Medicine, 35(6), pp.1443~1456 (2020), 대한내과학회[DOI]
- Enns GM, "The contribution of mitochondria to common disorders", Mol Genet Metab, 80, pp.11~26 (2003)
- Duchen MR, "Mitochondria in health and disease : perspectives on a new mitochondrial biology", Mol Aspects Med, 25, pp.365~451 (2004)
- Reis F, "Circadian and seasonal variation of endogenous ubiquinone plasma level", Chronobiol Int, 19, pp.599~614 (2002)